The FDA has scheduled an Oct. 15 meeting of its advisory committee to discuss whether to grant authorization for a booster dose of the J&J vaccine.
Related Articles
-
Pfizer vaccine for kids under 5 could be available by end of February
The Food and Drug Administration could expand the use of Pfizer-BioNTech’s Covid-19 vaccine to children ages 6 months to...
-
2-year-old Nevada boy dies from brain-eating amoeba after visit to hot spring
A 2-year-old boy from Nevada, died this week from a Naegleria fowleri infection, also known as a brain-eating amoeba,...
-
An injectable HIV-prevention drug is highly effective — but wildly expensive
The hotly anticipated results are in from a landmark pair of major clinical trials of a long-acting, injectable HIV-prevention...
-
England prepares to reopen on ‘Freedom Day’ despite skyrocketing Covid cases
Almost all lockdown restrictions are set to end in England on Monday, amid a rise in Covid-19 cases and...
-
Chlamydia vaccine shows promise in early trial
An early-stage clinical trial yielded promising results for a chlamydia vaccine, researchers reported Thursday in The Lancet Infectious Diseases. ...
-
DOD prepping answer to Oklahoma request to exempt National Guard from Covid vaccine mandate
The Pentagon is “preparing a written response” to the request by Oklahoma’s governor that his state’s National Guard be...
-
Popular weight loss drugs remain out of reach for many who need them
Dr. Laure DeMattia, a bariatric medicine specialist in Norman, Oklahoma, feels the frustration of her patients as they struggle...
-
Party over for Boris Johnson? U.K. leader fighting to save his job over lockdown scandal
LONDON — In May 2020 Dr. Hannah Barham-Brown would call multiple families each day from the two nursing homes...
Recent Comments